Evidence map›Paper›PMID 41257177›Full record

ArticleERJ open research2025

Diuretic adherence in patients with pre-capillary pulmonary hypertension: insights from the PHARE study.

Antoine Le Bozec, Samuel D Cohen, David Montani, Athénaïs Boucly, Christophe Guignabert, Anne Roche, Salma Al Kahf, Antoine Beurnier, Olivier Sitbon, Xavier Jaïs and 4 more

Abstract read
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antoine Le BozecAP-HP, Department of Pharmacy, Bicêtre Hospital, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-0789-5180
Samuel D CohenAP-HP, Department of Pharmacy, Bicêtre Hospital, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0001-5462-0625
David MontaniINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-9358-6922
Athénaïs BouclyINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0001-6246-5557
Christophe GuignabertINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-8545-4452
Anne RocheAP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
Salma Al KahfAP-HP, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, FHU André Cournand, ERN-LUNG, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
Antoine BeurnierINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-0481-3266
Olivier SitbonINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-1942-1951
Xavier JaïsINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.
Mitja JevnikarINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.
Marc HumbertINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0003-0703-2892
Laurent SavaleINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", HPPIT, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-6862-8975
Marie-Camille ChaumaisAP-HP, Department of Pharmacy, Bicêtre Hospital, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-1217-8442

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Supportive treatments, such as diuretics, play a critical role in managing pulmonary hypertension (PH). While low adherence to oral PH therapies worsens outcomes, the impact of diuretic adherence is less clear. This study aimed to determine diuretic adherence in patients managed for pre-capillary PH. Methods: This prospective, single-centre study, conducted from January 2022 to January 2024, evaluated medication adherence using the medication possession ratio (MPR) and a self-administered questionnaire (Girerd score). Factors contributing to low adherence and their potential association with serious clinical events were analysed. Results: Among the 220 patients included, 39% demonstrated low adherence to diuretics based on the MPR. According to the Girerd score, 28% of patients reported high adherence, 62% reported minor adherence issues and 10% reported low adherence to diuretics. Factors associated with low adherence measured by the MPR included younger age (<40 Conclusion: These findings suggest that low adherence to diuretics is frequent in PH and could be associated with worse outcomes. Future studies should assess whether detection of PH patients at risk of low adherence and subsequent targeted educational interventions may improve clinical outcomes.

Identifiers

PMID41257177
PMCPMC12621130

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.